nodes	percent_of_prediction	percent_of_DWPC	metapath
Azathioprine—GSTM1—Carboplatin—testicular cancer	0.26	0.349	CbGbCtD
Azathioprine—GSTM1—Cisplatin—testicular cancer	0.222	0.298	CbGbCtD
Azathioprine—XDH—Carboplatin—testicular cancer	0.108	0.145	CbGbCtD
Azathioprine—XDH—Cisplatin—testicular cancer	0.0924	0.124	CbGbCtD
Azathioprine—XDH—Doxorubicin—testicular cancer	0.0619	0.0831	CbGbCtD
Azathioprine—GSTA1—embryo—testicular cancer	0.00524	0.0894	CbGeAlD
Azathioprine—GSTA1—Glutathione conjugation—HPGDS—testicular cancer	0.00397	0.13	CbGpPWpGaD
Azathioprine—HPRT1—embryo—testicular cancer	0.00397	0.0678	CbGeAlD
Azathioprine—GSTA2—embryo—testicular cancer	0.00378	0.0645	CbGeAlD
Azathioprine—HPRT1—seminal vesicle—testicular cancer	0.00373	0.0636	CbGeAlD
Azathioprine—GSTA1—gonad—testicular cancer	0.00356	0.0607	CbGeAlD
Azathioprine—GSTA1—NRF2 pathway—SLC2A6—testicular cancer	0.00325	0.106	CbGpPWpGaD
Azathioprine—TPMT—seminal vesicle—testicular cancer	0.00315	0.0537	CbGeAlD
Azathioprine—GSTA1—female gonad—testicular cancer	0.00289	0.0493	CbGeAlD
Azathioprine—HPRT1—gonad—testicular cancer	0.0027	0.046	CbGeAlD
Azathioprine—GSTA2—Glutathione conjugation—HPGDS—testicular cancer	0.00268	0.0876	CbGpPWpGaD
Azathioprine—GSTM1—gonad—testicular cancer	0.00263	0.0449	CbGeAlD
Azathioprine—GSTM1—Glutathione conjugation—HPGDS—testicular cancer	0.00261	0.0853	CbGpPWpGaD
Azathioprine—GSTA2—gonad—testicular cancer	0.00257	0.0438	CbGeAlD
Azathioprine—GSTA1—testis—testicular cancer	0.00257	0.0437	CbGeAlD
Azathioprine—TPMT—gonad—testicular cancer	0.00227	0.0388	CbGeAlD
Azathioprine—GSTA2—NRF2 pathway—SLC2A6—testicular cancer	0.0022	0.0717	CbGpPWpGaD
Azathioprine—HPRT1—female gonad—testicular cancer	0.00219	0.0374	CbGeAlD
Azathioprine—GSTM1—female gonad—testicular cancer	0.00214	0.0365	CbGeAlD
Azathioprine—GSTM1—NRF2 pathway—SLC2A6—testicular cancer	0.00214	0.0697	CbGpPWpGaD
Azathioprine—GSTA2—female gonad—testicular cancer	0.00209	0.0356	CbGeAlD
Azathioprine—HPRT1—testis—testicular cancer	0.00194	0.0331	CbGeAlD
Azathioprine—GSTM1—testis—testicular cancer	0.0019	0.0324	CbGeAlD
Azathioprine—GSTA2—testis—testicular cancer	0.00185	0.0316	CbGeAlD
Azathioprine—TPMT—female gonad—testicular cancer	0.00185	0.0315	CbGeAlD
Azathioprine—GSTA1—Phase II conjugation—HPGDS—testicular cancer	0.00177	0.0578	CbGpPWpGaD
Azathioprine—TPMT—testis—testicular cancer	0.00164	0.028	CbGeAlD
Azathioprine—TPMT—Phase II conjugation—HPGDS—testicular cancer	0.00143	0.0466	CbGpPWpGaD
Azathioprine—HPRT1—lymph node—testicular cancer	0.00141	0.024	CbGeAlD
Azathioprine—GSTM1—lymph node—testicular cancer	0.00138	0.0235	CbGeAlD
Azathioprine—GSTM1—C-MYB transcription factor network—MAD1L1—testicular cancer	0.00126	0.0413	CbGpPWpGaD
Azathioprine—GSTA2—Phase II conjugation—HPGDS—testicular cancer	0.0012	0.039	CbGpPWpGaD
Azathioprine—TPMT—lymph node—testicular cancer	0.00119	0.0203	CbGeAlD
Azathioprine—GSTM1—Phase II conjugation—HPGDS—testicular cancer	0.00116	0.038	CbGpPWpGaD
Azathioprine—GSTA1—Biological oxidations—HPGDS—testicular cancer	0.00103	0.0338	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000882	0.0288	CbGpPWpGaD
Azathioprine—TPMT—Biological oxidations—HPGDS—testicular cancer	0.000834	0.0272	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—KITLG—testicular cancer	0.000811	0.0265	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—HPGDS—testicular cancer	0.000699	0.0228	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—HPGDS—testicular cancer	0.00068	0.0222	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—KIT—testicular cancer	0.000553	0.0181	CbGpPWpGaD
Azathioprine—Ill-defined disorder—Ifosfamide—testicular cancer	0.000264	0.00159	CcSEcCtD
Azathioprine—Gastrointestinal pain—Vinblastine—testicular cancer	0.000263	0.00159	CcSEcCtD
Azathioprine—Anaemia—Ifosfamide—testicular cancer	0.000263	0.00159	CcSEcCtD
Azathioprine—Discomfort—Dactinomycin—testicular cancer	0.000261	0.00158	CcSEcCtD
Azathioprine—Neoplasm—Epirubicin—testicular cancer	0.00026	0.00157	CcSEcCtD
Azathioprine—Hypersensitivity—Chlorambucil—testicular cancer	0.000258	0.00156	CcSEcCtD
Azathioprine—Malaise—Ifosfamide—testicular cancer	0.000256	0.00155	CcSEcCtD
Azathioprine—Colitis—Doxorubicin—testicular cancer	0.000256	0.00154	CcSEcCtD
Azathioprine—Leukopenia—Ifosfamide—testicular cancer	0.000254	0.00154	CcSEcCtD
Azathioprine—Immune system disorder—Cisplatin—testicular cancer	0.000254	0.00154	CcSEcCtD
Azathioprine—Abdominal pain—Vinblastine—testicular cancer	0.000254	0.00153	CcSEcCtD
Azathioprine—Mediastinal disorder—Cisplatin—testicular cancer	0.000254	0.00153	CcSEcCtD
Azathioprine—Hypotension—Bleomycin—testicular cancer	0.000254	0.00153	CcSEcCtD
Azathioprine—Infection—Dactinomycin—testicular cancer	0.000251	0.00152	CcSEcCtD
Azathioprine—Arrhythmia—Cisplatin—testicular cancer	0.000251	0.00152	CcSEcCtD
Azathioprine—Aplastic anaemia—Doxorubicin—testicular cancer	0.00025	0.00151	CcSEcCtD
Azathioprine—Alopecia—Cisplatin—testicular cancer	0.000249	0.0015	CcSEcCtD
Azathioprine—Hepatic failure—Methotrexate—testicular cancer	0.000248	0.0015	CcSEcCtD
Azathioprine—Thrombocytopenia—Dactinomycin—testicular cancer	0.000248	0.0015	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000247	0.00149	CcSEcCtD
Azathioprine—Erythema multiforme—Etoposide—testicular cancer	0.000244	0.00147	CcSEcCtD
Azathioprine—Arthralgia—Ifosfamide—testicular cancer	0.000242	0.00146	CcSEcCtD
Azathioprine—Myalgia—Ifosfamide—testicular cancer	0.000242	0.00146	CcSEcCtD
Azathioprine—Neoplasm—Doxorubicin—testicular cancer	0.000241	0.00145	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00024	0.00145	CcSEcCtD
Azathioprine—Diarrhoea—Chlorambucil—testicular cancer	0.00024	0.00145	CcSEcCtD
Azathioprine—Hepatic function abnormal—Epirubicin—testicular cancer	0.000239	0.00144	CcSEcCtD
Azathioprine—Discomfort—Ifosfamide—testicular cancer	0.000239	0.00144	CcSEcCtD
Azathioprine—Hypersensitivity—Vinblastine—testicular cancer	0.000237	0.00143	CcSEcCtD
Azathioprine—Immune system disorder—Etoposide—testicular cancer	0.000233	0.00141	CcSEcCtD
Azathioprine—Hepatic failure—Epirubicin—testicular cancer	0.000233	0.0014	CcSEcCtD
Azathioprine—Mediastinal disorder—Etoposide—testicular cancer	0.000232	0.0014	CcSEcCtD
Azathioprine—Chills—Etoposide—testicular cancer	0.000231	0.0014	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000231	0.00139	CcSEcCtD
Azathioprine—Infection—Ifosfamide—testicular cancer	0.00023	0.00139	CcSEcCtD
Azathioprine—Alopecia—Etoposide—testicular cancer	0.000228	0.00138	CcSEcCtD
Azathioprine—Ill-defined disorder—Cisplatin—testicular cancer	0.000227	0.00137	CcSEcCtD
Azathioprine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000227	0.00137	CcSEcCtD
Azathioprine—Anaemia—Cisplatin—testicular cancer	0.000226	0.00137	CcSEcCtD
Azathioprine—Skin disorder—Ifosfamide—testicular cancer	0.000225	0.00136	CcSEcCtD
Azathioprine—Feeling abnormal—Bleomycin—testicular cancer	0.000224	0.00135	CcSEcCtD
Azathioprine—Vomiting—Chlorambucil—testicular cancer	0.000223	0.00135	CcSEcCtD
Azathioprine—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000221	0.00134	CcSEcCtD
Azathioprine—Malaise—Cisplatin—testicular cancer	0.000221	0.00133	CcSEcCtD
Azathioprine—Diarrhoea—Vinblastine—testicular cancer	0.00022	0.00133	CcSEcCtD
Azathioprine—Leukopenia—Cisplatin—testicular cancer	0.000219	0.00132	CcSEcCtD
Azathioprine—Hypotension—Ifosfamide—testicular cancer	0.000217	0.00131	CcSEcCtD
Azathioprine—Hepatic failure—Doxorubicin—testicular cancer	0.000215	0.0013	CcSEcCtD
Azathioprine—Body temperature increased—Bleomycin—testicular cancer	0.000215	0.0013	CcSEcCtD
Azathioprine—Dizziness—Vinblastine—testicular cancer	0.000213	0.00128	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000211	0.00128	CcSEcCtD
Azathioprine—Myalgia—Cisplatin—testicular cancer	0.000209	0.00126	CcSEcCtD
Azathioprine—Feeling abnormal—Dactinomycin—testicular cancer	0.000209	0.00126	CcSEcCtD
Azathioprine—Nausea—Chlorambucil—testicular cancer	0.000208	0.00126	CcSEcCtD
Azathioprine—Ill-defined disorder—Etoposide—testicular cancer	0.000208	0.00126	CcSEcCtD
Azathioprine—Anaemia—Etoposide—testicular cancer	0.000207	0.00125	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000207	0.00125	CcSEcCtD
Azathioprine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000207	0.00125	CcSEcCtD
Azathioprine—Discomfort—Cisplatin—testicular cancer	0.000206	0.00124	CcSEcCtD
Azathioprine—Vomiting—Vinblastine—testicular cancer	0.000204	0.00123	CcSEcCtD
Azathioprine—HPRT1—Metabolism—HPGDS—testicular cancer	0.000202	0.00661	CbGpPWpGaD
Azathioprine—Malaise—Etoposide—testicular cancer	0.000202	0.00122	CcSEcCtD
Azathioprine—Headache—Vinblastine—testicular cancer	0.000201	0.00122	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000201	0.00121	CcSEcCtD
Azathioprine—Leukopenia—Etoposide—testicular cancer	0.000201	0.00121	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.0002	0.00121	CcSEcCtD
Azathioprine—Body temperature increased—Dactinomycin—testicular cancer	0.0002	0.00121	CcSEcCtD
Azathioprine—Abdominal pain—Dactinomycin—testicular cancer	0.0002	0.00121	CcSEcCtD
Azathioprine—Hypersensitivity—Bleomycin—testicular cancer	0.0002	0.00121	CcSEcCtD
Azathioprine—Infection—Cisplatin—testicular cancer	0.000199	0.0012	CcSEcCtD
Azathioprine—Thrombocytopenia—Cisplatin—testicular cancer	0.000196	0.00118	CcSEcCtD
Azathioprine—Skin disorder—Cisplatin—testicular cancer	0.000194	0.00117	CcSEcCtD
Azathioprine—Feeling abnormal—Ifosfamide—testicular cancer	0.000191	0.00115	CcSEcCtD
Azathioprine—Nausea—Vinblastine—testicular cancer	0.000191	0.00115	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00019	0.00115	CcSEcCtD
Azathioprine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00019	0.00115	CcSEcCtD
Azathioprine—Pancreatitis—Methotrexate—testicular cancer	0.000189	0.00114	CcSEcCtD
Azathioprine—Discomfort—Etoposide—testicular cancer	0.000189	0.00114	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000188	0.00114	CcSEcCtD
Azathioprine—Hypotension—Cisplatin—testicular cancer	0.000187	0.00113	CcSEcCtD
Azathioprine—Hypersensitivity—Dactinomycin—testicular cancer	0.000187	0.00113	CcSEcCtD
Azathioprine—Abdominal discomfort—Methotrexate—testicular cancer	0.000185	0.00112	CcSEcCtD
Azathioprine—Abdominal pain—Ifosfamide—testicular cancer	0.000183	0.00111	CcSEcCtD
Azathioprine—Body temperature increased—Ifosfamide—testicular cancer	0.000183	0.00111	CcSEcCtD
Azathioprine—Pancytopenia—Methotrexate—testicular cancer	0.000183	0.00111	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000182	0.0011	CcSEcCtD
Azathioprine—Infection—Etoposide—testicular cancer	0.000182	0.0011	CcSEcCtD
Azathioprine—Thrombocytopenia—Etoposide—testicular cancer	0.000179	0.00108	CcSEcCtD
Azathioprine—Skin disorder—Etoposide—testicular cancer	0.000178	0.00107	CcSEcCtD
Azathioprine—Pancreatitis—Epirubicin—testicular cancer	0.000177	0.00107	CcSEcCtD
Azathioprine—GSTA1—Metabolism—HPGDS—testicular cancer	0.000177	0.00578	CbGpPWpGaD
Azathioprine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000174	0.00105	CcSEcCtD
Azathioprine—Diarrhoea—Dactinomycin—testicular cancer	0.000173	0.00105	CcSEcCtD
Azathioprine—Pneumonia—Methotrexate—testicular cancer	0.000173	0.00105	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000173	0.00104	CcSEcCtD
Azathioprine—Vomiting—Bleomycin—testicular cancer	0.000173	0.00104	CcSEcCtD
Azathioprine—Infestation NOS—Methotrexate—testicular cancer	0.000172	0.00104	CcSEcCtD
Azathioprine—Infestation—Methotrexate—testicular cancer	0.000172	0.00104	CcSEcCtD
Azathioprine—Pancytopenia—Epirubicin—testicular cancer	0.000172	0.00104	CcSEcCtD
Azathioprine—Hypotension—Etoposide—testicular cancer	0.000171	0.00103	CcSEcCtD
Azathioprine—Rash—Bleomycin—testicular cancer	0.000171	0.00103	CcSEcCtD
Azathioprine—Dermatitis—Bleomycin—testicular cancer	0.000171	0.00103	CcSEcCtD
Azathioprine—Hypersensitivity—Ifosfamide—testicular cancer	0.000171	0.00103	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000171	0.00103	CcSEcCtD
Azathioprine—Feeling abnormal—Cisplatin—testicular cancer	0.000165	0.000995	CcSEcCtD
Azathioprine—Pancreatitis—Doxorubicin—testicular cancer	0.000164	0.000989	CcSEcCtD
Azathioprine—Hepatobiliary disease—Methotrexate—testicular cancer	0.000163	0.000983	CcSEcCtD
Azathioprine—Pneumonia—Epirubicin—testicular cancer	0.000162	0.000978	CcSEcCtD
Azathioprine—Nausea—Bleomycin—testicular cancer	0.000161	0.000974	CcSEcCtD
Azathioprine—Infestation NOS—Epirubicin—testicular cancer	0.000161	0.000973	CcSEcCtD
Azathioprine—Infestation—Epirubicin—testicular cancer	0.000161	0.000973	CcSEcCtD
Azathioprine—Vomiting—Dactinomycin—testicular cancer	0.000161	0.000972	CcSEcCtD
Azathioprine—Agranulocytosis—Methotrexate—testicular cancer	0.000161	0.00097	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00016	0.000964	CcSEcCtD
Azathioprine—Rash—Dactinomycin—testicular cancer	0.00016	0.000964	CcSEcCtD
Azathioprine—Diarrhoea—Ifosfamide—testicular cancer	0.000159	0.000959	CcSEcCtD
Azathioprine—Pancytopenia—Doxorubicin—testicular cancer	0.000159	0.000958	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000158	0.000955	CcSEcCtD
Azathioprine—Body temperature increased—Cisplatin—testicular cancer	0.000158	0.000955	CcSEcCtD
Azathioprine—Haemoglobin—Methotrexate—testicular cancer	0.000155	0.000938	CcSEcCtD
Azathioprine—Haemorrhage—Methotrexate—testicular cancer	0.000154	0.000933	CcSEcCtD
Azathioprine—Dizziness—Ifosfamide—testicular cancer	0.000153	0.000926	CcSEcCtD
Azathioprine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000152	0.00092	CcSEcCtD
Azathioprine—Feeling abnormal—Etoposide—testicular cancer	0.000151	0.000912	CcSEcCtD
Azathioprine—Nausea—Dactinomycin—testicular cancer	0.00015	0.000908	CcSEcCtD
Azathioprine—Agranulocytosis—Epirubicin—testicular cancer	0.00015	0.000908	CcSEcCtD
Azathioprine—Pneumonia—Doxorubicin—testicular cancer	0.00015	0.000905	CcSEcCtD
Azathioprine—Gastrointestinal pain—Etoposide—testicular cancer	0.00015	0.000905	CcSEcCtD
Azathioprine—Infestation—Doxorubicin—testicular cancer	0.000149	0.0009	CcSEcCtD
Azathioprine—Infestation NOS—Doxorubicin—testicular cancer	0.000149	0.0009	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000148	0.000892	CcSEcCtD
Azathioprine—Vomiting—Ifosfamide—testicular cancer	0.000147	0.000891	CcSEcCtD
Azathioprine—Hypersensitivity—Cisplatin—testicular cancer	0.000147	0.00089	CcSEcCtD
Azathioprine—HPRT1—Metabolism—STK11—testicular cancer	0.000147	0.0048	CbGpPWpGaD
Azathioprine—Rash—Ifosfamide—testicular cancer	0.000146	0.000883	CcSEcCtD
Azathioprine—Dermatitis—Ifosfamide—testicular cancer	0.000146	0.000883	CcSEcCtD
Azathioprine—Erythema multiforme—Methotrexate—testicular cancer	0.000146	0.000882	CcSEcCtD
Azathioprine—Haemoglobin—Epirubicin—testicular cancer	0.000145	0.000877	CcSEcCtD
Azathioprine—Abdominal pain—Etoposide—testicular cancer	0.000145	0.000875	CcSEcCtD
Azathioprine—Body temperature increased—Etoposide—testicular cancer	0.000145	0.000875	CcSEcCtD
Azathioprine—Haemorrhage—Epirubicin—testicular cancer	0.000145	0.000873	CcSEcCtD
Azathioprine—TPMT—Metabolism—HPGDS—testicular cancer	0.000143	0.00466	CbGpPWpGaD
Azathioprine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000141	0.000851	CcSEcCtD
Azathioprine—Immune system disorder—Methotrexate—testicular cancer	0.00014	0.000843	CcSEcCtD
Azathioprine—Mediastinal disorder—Methotrexate—testicular cancer	0.000139	0.000841	CcSEcCtD
Azathioprine—Agranulocytosis—Doxorubicin—testicular cancer	0.000139	0.00084	CcSEcCtD
Azathioprine—Chills—Methotrexate—testicular cancer	0.000139	0.000837	CcSEcCtD
Azathioprine—Nausea—Ifosfamide—testicular cancer	0.000138	0.000832	CcSEcCtD
Azathioprine—Diarrhoea—Cisplatin—testicular cancer	0.000137	0.000826	CcSEcCtD
Azathioprine—Erythema multiforme—Epirubicin—testicular cancer	0.000137	0.000825	CcSEcCtD
Azathioprine—Alopecia—Methotrexate—testicular cancer	0.000137	0.000824	CcSEcCtD
Azathioprine—Hypersensitivity—Etoposide—testicular cancer	0.000135	0.000815	CcSEcCtD
Azathioprine—Haemoglobin—Doxorubicin—testicular cancer	0.000134	0.000812	CcSEcCtD
Azathioprine—Haemorrhage—Doxorubicin—testicular cancer	0.000134	0.000808	CcSEcCtD
Azathioprine—Immune system disorder—Epirubicin—testicular cancer	0.000131	0.000789	CcSEcCtD
Azathioprine—Mediastinal disorder—Epirubicin—testicular cancer	0.00013	0.000787	CcSEcCtD
Azathioprine—Chills—Epirubicin—testicular cancer	0.00013	0.000783	CcSEcCtD
Azathioprine—Arrhythmia—Epirubicin—testicular cancer	0.000129	0.00078	CcSEcCtD
Azathioprine—GSTA1—Metabolism—STK11—testicular cancer	0.000129	0.0042	CbGpPWpGaD
Azathioprine—Alopecia—Epirubicin—testicular cancer	0.000128	0.000771	CcSEcCtD
Azathioprine—Vomiting—Cisplatin—testicular cancer	0.000127	0.000768	CcSEcCtD
Azathioprine—Erythema multiforme—Doxorubicin—testicular cancer	0.000126	0.000764	CcSEcCtD
Azathioprine—Rash—Cisplatin—testicular cancer	0.000126	0.000762	CcSEcCtD
Azathioprine—Dermatitis—Cisplatin—testicular cancer	0.000126	0.000761	CcSEcCtD
Azathioprine—Diarrhoea—Etoposide—testicular cancer	0.000125	0.000757	CcSEcCtD
Azathioprine—Ill-defined disorder—Methotrexate—testicular cancer	0.000125	0.000754	CcSEcCtD
Azathioprine—Anaemia—Methotrexate—testicular cancer	0.000124	0.000751	CcSEcCtD
Azathioprine—Malaise—Methotrexate—testicular cancer	0.000121	0.000732	CcSEcCtD
Azathioprine—Dizziness—Etoposide—testicular cancer	0.000121	0.000732	CcSEcCtD
Azathioprine—Immune system disorder—Doxorubicin—testicular cancer	0.000121	0.00073	CcSEcCtD
Azathioprine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000121	0.000728	CcSEcCtD
Azathioprine—Leukopenia—Methotrexate—testicular cancer	0.00012	0.000727	CcSEcCtD
Azathioprine—Chills—Doxorubicin—testicular cancer	0.00012	0.000725	CcSEcCtD
Azathioprine—GSTA2—Metabolism—HPGDS—testicular cancer	0.00012	0.0039	CbGpPWpGaD
Azathioprine—Arrhythmia—Doxorubicin—testicular cancer	0.000119	0.000722	CcSEcCtD
Azathioprine—Nausea—Cisplatin—testicular cancer	0.000119	0.000717	CcSEcCtD
Azathioprine—Alopecia—Doxorubicin—testicular cancer	0.000118	0.000714	CcSEcCtD
Azathioprine—Ill-defined disorder—Epirubicin—testicular cancer	0.000117	0.000705	CcSEcCtD
Azathioprine—Vomiting—Etoposide—testicular cancer	0.000116	0.000704	CcSEcCtD
Azathioprine—Anaemia—Epirubicin—testicular cancer	0.000116	0.000702	CcSEcCtD
Azathioprine—GSTM1—Metabolism—HPGDS—testicular cancer	0.000116	0.0038	CbGpPWpGaD
Azathioprine—Rash—Etoposide—testicular cancer	0.000116	0.000698	CcSEcCtD
Azathioprine—Dermatitis—Etoposide—testicular cancer	0.000115	0.000697	CcSEcCtD
Azathioprine—Headache—Etoposide—testicular cancer	0.000115	0.000693	CcSEcCtD
Azathioprine—Myalgia—Methotrexate—testicular cancer	0.000114	0.000691	CcSEcCtD
Azathioprine—Arthralgia—Methotrexate—testicular cancer	0.000114	0.000691	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000114	0.000687	CcSEcCtD
Azathioprine—Malaise—Epirubicin—testicular cancer	0.000113	0.000685	CcSEcCtD
Azathioprine—Discomfort—Methotrexate—testicular cancer	0.000113	0.000683	CcSEcCtD
Azathioprine—Leukopenia—Epirubicin—testicular cancer	0.000113	0.00068	CcSEcCtD
Azathioprine—Infection—Methotrexate—testicular cancer	0.000109	0.000658	CcSEcCtD
Azathioprine—Nausea—Etoposide—testicular cancer	0.000109	0.000657	CcSEcCtD
Azathioprine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000108	0.000652	CcSEcCtD
Azathioprine—Anaemia—Doxorubicin—testicular cancer	0.000108	0.00065	CcSEcCtD
Azathioprine—Thrombocytopenia—Methotrexate—testicular cancer	0.000107	0.000649	CcSEcCtD
Azathioprine—Arthralgia—Epirubicin—testicular cancer	0.000107	0.000647	CcSEcCtD
Azathioprine—Myalgia—Epirubicin—testicular cancer	0.000107	0.000647	CcSEcCtD
Azathioprine—Skin disorder—Methotrexate—testicular cancer	0.000107	0.000644	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000106	0.000643	CcSEcCtD
Azathioprine—Discomfort—Epirubicin—testicular cancer	0.000106	0.000639	CcSEcCtD
Azathioprine—Malaise—Doxorubicin—testicular cancer	0.000105	0.000634	CcSEcCtD
Azathioprine—Leukopenia—Doxorubicin—testicular cancer	0.000104	0.000629	CcSEcCtD
Azathioprine—TPMT—Metabolism—STK11—testicular cancer	0.000104	0.00338	CbGpPWpGaD
Azathioprine—Hypotension—Methotrexate—testicular cancer	0.000103	0.000619	CcSEcCtD
Azathioprine—Infection—Epirubicin—testicular cancer	0.000102	0.000616	CcSEcCtD
Azathioprine—Thrombocytopenia—Epirubicin—testicular cancer	0.000101	0.000607	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.0001	0.000604	CcSEcCtD
Azathioprine—Skin disorder—Epirubicin—testicular cancer	9.98e-05	0.000602	CcSEcCtD
Azathioprine—Myalgia—Doxorubicin—testicular cancer	9.91e-05	0.000599	CcSEcCtD
Azathioprine—Arthralgia—Doxorubicin—testicular cancer	9.91e-05	0.000599	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	9.84e-05	0.000595	CcSEcCtD
Azathioprine—Discomfort—Doxorubicin—testicular cancer	9.79e-05	0.000592	CcSEcCtD
Azathioprine—Hypotension—Epirubicin—testicular cancer	9.6e-05	0.00058	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Methotrexate—testicular cancer	9.47e-05	0.000572	CcSEcCtD
Azathioprine—Infection—Doxorubicin—testicular cancer	9.44e-05	0.00057	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.36e-05	0.000565	CcSEcCtD
Azathioprine—Thrombocytopenia—Doxorubicin—testicular cancer	9.3e-05	0.000562	CcSEcCtD
Azathioprine—Skin disorder—Doxorubicin—testicular cancer	9.23e-05	0.000557	CcSEcCtD
Azathioprine—Feeling abnormal—Methotrexate—testicular cancer	9.04e-05	0.000546	CcSEcCtD
Azathioprine—Gastrointestinal pain—Methotrexate—testicular cancer	8.97e-05	0.000542	CcSEcCtD
Azathioprine—Hypotension—Doxorubicin—testicular cancer	8.88e-05	0.000536	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Epirubicin—testicular cancer	8.87e-05	0.000535	CcSEcCtD
Azathioprine—GSTA2—Metabolism—STK11—testicular cancer	8.69e-05	0.00284	CbGpPWpGaD
Azathioprine—Abdominal pain—Methotrexate—testicular cancer	8.68e-05	0.000524	CcSEcCtD
Azathioprine—Body temperature increased—Methotrexate—testicular cancer	8.68e-05	0.000524	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.66e-05	0.000523	CcSEcCtD
Azathioprine—XDH—Metabolism—HPGDS—testicular cancer	8.64e-05	0.00282	CbGpPWpGaD
Azathioprine—Feeling abnormal—Epirubicin—testicular cancer	8.46e-05	0.000511	CcSEcCtD
Azathioprine—GSTM1—Metabolism—STK11—testicular cancer	8.45e-05	0.00276	CbGpPWpGaD
Azathioprine—Gastrointestinal pain—Epirubicin—testicular cancer	8.4e-05	0.000507	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.2e-05	0.000495	CcSEcCtD
Azathioprine—Body temperature increased—Epirubicin—testicular cancer	8.12e-05	0.00049	CcSEcCtD
Azathioprine—Abdominal pain—Epirubicin—testicular cancer	8.12e-05	0.00049	CcSEcCtD
Azathioprine—Hypersensitivity—Methotrexate—testicular cancer	8.09e-05	0.000488	CcSEcCtD
Azathioprine—Feeling abnormal—Doxorubicin—testicular cancer	7.83e-05	0.000473	CcSEcCtD
Azathioprine—Gastrointestinal pain—Doxorubicin—testicular cancer	7.77e-05	0.000469	CcSEcCtD
Azathioprine—Hypersensitivity—Epirubicin—testicular cancer	7.57e-05	0.000457	CcSEcCtD
Azathioprine—Abdominal pain—Doxorubicin—testicular cancer	7.51e-05	0.000454	CcSEcCtD
Azathioprine—Body temperature increased—Doxorubicin—testicular cancer	7.51e-05	0.000454	CcSEcCtD
Azathioprine—Diarrhoea—Methotrexate—testicular cancer	7.51e-05	0.000453	CcSEcCtD
Azathioprine—Dizziness—Methotrexate—testicular cancer	7.26e-05	0.000438	CcSEcCtD
Azathioprine—Diarrhoea—Epirubicin—testicular cancer	7.03e-05	0.000424	CcSEcCtD
Azathioprine—Hypersensitivity—Doxorubicin—testicular cancer	7e-05	0.000423	CcSEcCtD
Azathioprine—Vomiting—Methotrexate—testicular cancer	6.98e-05	0.000421	CcSEcCtD
Azathioprine—Rash—Methotrexate—testicular cancer	6.92e-05	0.000418	CcSEcCtD
Azathioprine—Dermatitis—Methotrexate—testicular cancer	6.91e-05	0.000418	CcSEcCtD
Azathioprine—Headache—Methotrexate—testicular cancer	6.88e-05	0.000415	CcSEcCtD
Azathioprine—Dizziness—Epirubicin—testicular cancer	6.79e-05	0.00041	CcSEcCtD
Azathioprine—Vomiting—Epirubicin—testicular cancer	6.53e-05	0.000394	CcSEcCtD
Azathioprine—Nausea—Methotrexate—testicular cancer	6.52e-05	0.000394	CcSEcCtD
Azathioprine—Diarrhoea—Doxorubicin—testicular cancer	6.5e-05	0.000393	CcSEcCtD
Azathioprine—Rash—Epirubicin—testicular cancer	6.48e-05	0.000391	CcSEcCtD
Azathioprine—Dermatitis—Epirubicin—testicular cancer	6.47e-05	0.000391	CcSEcCtD
Azathioprine—Headache—Epirubicin—testicular cancer	6.43e-05	0.000389	CcSEcCtD
Azathioprine—Dizziness—Doxorubicin—testicular cancer	6.28e-05	0.00038	CcSEcCtD
Azathioprine—XDH—Metabolism—STK11—testicular cancer	6.28e-05	0.00205	CbGpPWpGaD
Azathioprine—Nausea—Epirubicin—testicular cancer	6.1e-05	0.000368	CcSEcCtD
Azathioprine—Vomiting—Doxorubicin—testicular cancer	6.04e-05	0.000365	CcSEcCtD
Azathioprine—Rash—Doxorubicin—testicular cancer	5.99e-05	0.000362	CcSEcCtD
Azathioprine—Dermatitis—Doxorubicin—testicular cancer	5.99e-05	0.000362	CcSEcCtD
Azathioprine—Headache—Doxorubicin—testicular cancer	5.95e-05	0.00036	CcSEcCtD
Azathioprine—Nausea—Doxorubicin—testicular cancer	5.64e-05	0.000341	CcSEcCtD
